NMPA Approval

Recombinant Human Follitropin Prefilled Syringe

Approval Number

国药准字S20240002

Company长春金赛药业有限责任公司

Registration Date

January 5, 2024

Drug Information

Generic Name

重组人促卵泡激素注射液

Dosage Form

注射剂

Strength

33μg（450IU）

Drug Type

生物制品

Registration Date

January 5, 2024

Company Information

Applicant Company

Company Name长春金赛药业有限责任公司

Company Address

长春高新开发区天河街72号

Manufacturing Company

Company Name长春金赛药业有限责任公司

Company Address

长春市高新技术产业开发区越达路1718号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

重组人促卵泡激素注射液 - NMPA 批准文号 | MedPath